Diabetes Health Gains Outpace Economic Progress, Study Finds
ChatGPT Effectively Answers Patient Questions on CRC Screening
Access to Minimally Invasive Surgery for Advanced Ovarian Cancer Varies Widely by Facility
Retifanlimab Becomes First FDA-Approved Frontline Treatment for Advanced Anal Cancer
Specialty Drug Users to Gain Relief Under Medicare Reforms
New Executive Order Aims for Most-Favored Nation Pricing: John Barkett, MBA
Spotlighting Innovations in Pulmonary Care at ATS 2025
AJMC® in the Press, May 16, 2025
Dual Therapy Appears to Benefit Patients With Pulmonary Fibrosis, Pulmonary Hypertension
Rozanolixizumab for gMG Approved in Japan for Self-Administration
Novel AI-Based Score Could Pinpoint AF Risk in Patients With CLL on BTKis
Implementation of HIV Molecular Cluster Detection in US
Impedance Cardiography Offers Noninvasive Insight Into PAH Progression
RFK Jr Claims HHS Has Not Fired Working Scientists, Canceled Lifesaving Research
Anti-Inflammatory Diets May Help Reduce Risk of Alzheimer Disease–Related Death
Lebrikizumab Improves Quality of Life, Disease Control in Patients With Atopic Dermatitis
Infant RSV Hospitalization Rates Drop in First Season With Widespread Preventive Product Use
Future Research Priorities for Non-Hodgkin Lymphomas: Craig A. Portell, MD
PICO sNPWT Significantly Reduces C-Section Complications, Lowers Cost, Study Finds
Teliso-V Approved to Treat Advanced NSCLC With High c-Met Protein Overexpression
Flow Cytometry Can Reliably Identify CTC in Melanoma
3 Maternal Risk Factors Linked to Elevated Offspring Blood Pressure
Quantitative Magnetic Resonance Outcomes Suggest Gene Therapy Slows DMD Progression
Lower Odds of Cataract Associated With Antioxidant Index
MIGS Offers Multiple Methods of Addressing Glaucoma Early: Christine Funke, MD
New Jersey’s First Freestanding Cancer Hospital Opens in New Brunswick
ART, Tuberculosis Prevention Treatments Effective When Taken Simultaneously
Pediatric Patients With Myasthenia Gravis Need More Treatment Options: Jonathan Strober, MD
Remote Symptom Monitoring Linked to Reduced Hospitalization Risk for Patients With Cancer
Real-World Data Show Bevacizumab Benefits Only High-Risk Patients With Epithelial Ovarian Cancer